Liraglutide-Induced Hepatotoxicity-MedSci.cn

Liraglutide-Induced Hepatotoxicity

Maor, Y; Ergaz, D; Malnick, SDH; Melzer, E; Neuman, MG

Neuman, MG (corresponding author), Univ Toronto, Vitro Drug Safety & Biotechnol, Toronto, ON M5G 1L5, Canada.; Neuman, MG (corresponding author), Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5G 1L5, Canada.

BIOMEDICINES, 2021; 9 (2):

Abstract

A 52-year-old woman with a BMI of 31.2 kg/m(2) was treated with the glucagon-like peptide 1 (GLP-1) agonist liraglutide as part of her weight-reductio......

Full Text Link